Gene · 3535
Papers1,872
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,872
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EDNRA-Expressing Mesenchymal Cells Are Expanded in Myeloma Interstitial Bone Marrow and Associated with Disease Progression. | Cancers (Basel) | 2023 | 37760488 | PubTator, text mining | PubMed |
| B cell responses to membrane-presented antigens require the function of the mechanosensitive cation channel Piezo1. | Sci Signal | 2023 | 37751477 | PubTator, text mining | PubMed |
| [IGL-CCND1 positive mantle cell lymphoma: a case report and literature review]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37749044 | PubTator, text mining | PubMed |
| [Dual epigenetic therapy in TET2 gene positive extranodal peripheral T-cell lymphoma with follicular helper T-cell (TFH) phenotype: a case report and literature review]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37749042 | PubTator, text mining | PubMed |
| Dynamic single-cell mapping unveils Epstein‒Barr virus-imprinted T-cell exhaustion and on-treatment response. | Signal Transduct Target Ther | 2023 | 37735150 | PubTator, text mining | PubMed |
| miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance. | Technol Cancer Res Treat | 2023 | 37728167 | PubTator, text mining | PubMed |
| Role of stress in the pathogenesis of cancer (Review). | Int J Oncol | 2023 | 37711028 | PubTator, text mining | PubMed |
| Expanding the Clinical Utility of Targeted RNA Sequencing Panels beyond Gene Fusions to Complex, Intragenic Structural Rearrangements. | Cancers (Basel) | 2023 | 37686670 | PubTator, text mining | PubMed |
| Exosomal MicroRNA and Protein Profiles of Hepatitis B Virus-Related Hepatocellular Carcinoma Cells. | Int J Mol Sci | 2023 | 37685904 | PubTator, text mining | PubMed |
| Bright light treatment counteracts stress-induced sleep alterations in mice, via a visual circuit related to the rostromedial tegmental nucleus. | PLoS Biol | 2023 | 37676855 | PubTator, text mining | PubMed |
| Infant antibody and B-cell responses following confirmed pediatric GII.17 norovirus infections functionally distinguish GII.17 genetic clusters. | Front Immunol | 2023 | 37662930 | PubTator, text mining | PubMed |
| Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension. | Int J Mol Sci | 2023 | 37628831 | PubTator, text mining | PubMed |
| Occurrence, Distribution and Toxins of Benthic Cyanobacteria in German Lakes. | Toxics | 2023 | 37624149 | PubTator, text mining | PubMed |
| Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma. | Front Immunol | 2023 | 37622116 | PubTator, text mining | PubMed |
| Schizophrenia-associated somatic copy-number variants from 12,834 cases reveal recurrent NRXN1 and ABCB11 disruptions. | Cell Genom | 2023 | 37601975 | PubTator, text mining | PubMed |
Humoral immune reconstitution following therapy with daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara-KRd), autologous hematopoietic cell transplantation, and measurable residual disease-response-adapted treatment cessation. | EJHaem | 2023 | 37601885 | PubTator, text mining | PubMed |
| Multimodal, broadly neutralizing antibodies against SARS-CoV-2 identified by high-throughput native pairing of BCRs from bulk B cells. | Cell Chem Biol | 2023 | 37586370 | PubTator, text mining | PubMed |
| Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax. | Int J Hematol | 2023 | 37581752 | PubTator, text mining | PubMed |
| A novel PRKDC mutation caused B lymphocytes V(D)J rearrangement disorder in the SLE-DAH like symptoms patient. | Pediatr Rheumatol Online J | 2023 | 37580814 | PubTator, text mining | PubMed |
| The landscape of the immunoglobulin repertoire in endemic pemphigus foliaceus. | Front Immunol | 2023 | 37575223 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3535/papers?page=7